HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nagahiko Sakuma Selected Research
Nagahiko Sakuma Research Topics
Disease
4
Atherosclerosis
09/2018 - 01/2002
2
Sitosterolemia
09/2018 - 12/2017
2
Coronary Artery Disease (Coronary Atherosclerosis)
06/2009 - 11/2003
1
Xanthomatosis (Xanthoma)
09/2018
1
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2014
1
Hyperlipoproteinemia Type III (Broad Beta Disease)
01/2014
1
Cardiovascular Diseases (Cardiovascular Disease)
06/2009
1
Hypercholesterolemia
06/2009
1
Alcoholic Cardiomyopathy
01/2008
1
Hypertriglyceridemia
11/2003
Drug/Important Bio-Agent (IBA)
3
oxidized low density lipoprotein
IBA
09/2018 - 08/2002
2
LDL Cholesterol
IBA
09/2018 - 01/2002
2
Cholesterol
IBA
11/2003 - 01/2002
1
Phytosterols (Plant Sterols)
IBA
09/2018
1
colestimide
IBA
09/2018
1
Ezetimibe (Zetia)
FDA Link
09/2018
1
Proprotein Convertase 9
IBA
09/2018
1
gamma-sitosterol (beta-sitosterol)
IBA
09/2018
1
PCSK9 Inhibitors
IBA
09/2018
1
Lipoproteins (Lipoprotein)
IBA
12/2017
1
Arginine (L-Arginine)
FDA Link
01/2014
1
Apolipoproteins E (ApoE)
IBA
01/2014
1
Amino Acids
FDA Link
01/2014
1
LDL Receptors (LDL Receptor)
IBA
01/2014
1
apolipoprotein E1
IBA
01/2014
1
Apolipoprotein E2
IBA
01/2014
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
06/2009
1
Acetaldehyde
IBA
01/2008
1
HDL Cholesterol
IBA
11/2003
1
Triglycerides (Triacylglycerol)
IBA
11/2003
1
Bezafibrate
IBA
11/2003
1
HDL2 Lipoproteins
IBA
11/2003
1
Lipids
IBA
01/2002
Therapy/Procedure
2
Blood Component Removal (Apheresis)
09/2018 - 12/2017
1
Therapeutics
09/2018
1
Percutaneous Coronary Intervention
06/2009